AcryMed Overview
- Founded
- 1993
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Latest Deal Amount
- $26.7M
- Investors
- 1
AcryMed General Information
Description
Developer of a proprietary wound care technologies. The company has focused their efforts on identifying solutions to enhance the efficacy of medical products and improve patient care.
Contact Information
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 9560 South West Nimbus Avenue
- Beaverton, OR 97008
- United States
+1 (503) 000-0000
AcryMed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 15-Feb-2008 | $26.7M | 00.00 | 000.00 | Completed | Generating Revenue |
| 2. Early Stage VC | 01-Jan-1996 | 00.00 | 00.00 | Completed | Startup | |
| 1. Early Stage VC | 01-Jan-1995 | $900K | $900K | Completed | Startup |
AcryMed Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Dan Pike Ph.D | General Manager & Business Development Leader |
AcryMed Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Fluke Venture Partners | Family Office | Minority | 000 0000 | 000000 0 | |
| Pacific Northwest Partners | Corporation | Minority | 000 0000 | 000000 0 |